Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Politicians who traded ROIV
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 4
- Filings
- 2
- Politicians
- 1
- Buys / sells
- 2 / 2
- Estimated volume
- $32.0K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Lisa C. McClain House · MI | 4 | 2 / 2 | $32.0K | Oct 31, 2025 | Nov 21, 2025 |
Trades
Reported trades in Roivant Sciences Ltd., newest filings first.
| Politician | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
Lisa C. McClain House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Sell | Spouse | Oct 30, 2025 | Nov 21, 2025 | 22 days | $1K-$15K | Filing |
Lisa C. McClain House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Buy | Spouse | Oct 30, 2025 | Nov 21, 2025 | 22 days | $1K-$15K | Filing |
Lisa C. McClain House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Sell | Spouse | Oct 31, 2025 | Nov 21, 2025 | 21 days | $1K-$15K | Filing |
Lisa C. McClain House · MI | ROIVRoivant Sciences Ltd. - Common Shares | Buy | Spouse | Jun 17, 2025 | Aug 13, 2025 | 57 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.